Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Repligen Corporation - Common Stock
(NQ:
RGEN
)
143.24
+2.01 (+1.42%)
Streaming Delayed Price
Updated: 3:00 PM EDT, Jul 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Repligen Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
March 12, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Azenta (NASDAQ:AZTA) and its peers.
Via
StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
March 11, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...
Via
StockStory
3 Small-Cap Stocks Skating on Thin Ice
March 06, 2025
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...
Via
StockStory
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
↗
March 04, 2025
Repligen acquires 908 Devices' desktop portfolio for $70 million, enhancing its bioprocessing analytics. 908 Devices shifts focus to handheld growth, forecasting revenue gains.
Via
Benzinga
The Analyst Verdict: Repligen In The Eyes Of 4 Experts
↗
February 21, 2025
Via
Benzinga
Earnings Scheduled For February 20, 2025
↗
February 20, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Evaluating Repligen: Insights From 6 Financial Analysts
↗
September 26, 2024
Via
Benzinga
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
↗
July 31, 2024
Via
Benzinga
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
↗
February 20, 2025
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.
Via
Benzinga
Repligen's Q4 Slightly Tops Expectations
↗
February 20, 2025
The bioprocessing technology specialist's fourth-quarter results were dragged down by restructuring costs.
Via
The Motley Fool
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
February 20, 2025
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $167.5 million. The company’s outlook for the...
Via
StockStory
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
February 19, 2025
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what you need to know.
Via
StockStory
3 Healthcare Stocks Skating on Thin Ice
February 12, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...
Via
StockStory
Topics
Stocks
Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tuesday Session
April 23, 2024
Via
Investor Brand Network
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
↗
November 12, 2024
Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.
Via
Benzinga
Topics
Earnings
10 Health Care Stocks Whale Activity In Today's Session
↗
November 12, 2024
Via
Benzinga
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
↗
August 16, 2024
Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York.
Via
Benzinga
Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
↗
August 04, 2024
Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio!
Via
Benzinga
Here's Why Shares in This Hot Healthcare Stock Surged This Week
↗
August 02, 2024
The bioprocessing market is preparing for a recovery.
Via
The Motley Fool
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
July 30, 2024
Via
Benzinga
Repligen Lowers Guidance On China Weakness, Analyst Expects
↗
July 30, 2024
Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from 50.2%, with an EPS of $0.33. CEO Tony J. Hunt highlights strong Pharma...
Via
Benzinga
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
↗
July 30, 2024
Via
Benzinga
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
↗
June 26, 2024
Via
Benzinga
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
June 26, 2024
Via
Benzinga
Top 3 Health Care Stocks That Could Blast Off In June
↗
June 21, 2024
Via
Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 13, 2024
Via
Benzinga
RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024
↗
May 01, 2024
RGEN stock results show that Repligen missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
↗
April 23, 2024
Via
Benzinga
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
↗
March 25, 2024
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
